Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AEZS | D | AEterna Zentaris Inc. | 4.97 | |
AFMD | D | Affimed Therapeutics B.V. | 0.29 | |
AGRX | F | Agile Therapeutics, Inc. | -2.53 | |
ALNY | C | Alnylam Pharmaceuticals, Inc. | -0.59 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 1.79 | |
APRE | D | Aprea Therapeutics, Inc. | 1.64 | |
ATRA | F | Atara Biotherapeutics, Inc. | -2.91 | |
AUPH | F | Aurinia Pharmaceuticals Inc | -2.90 | |
AXSM | D | Axsome Therapeutics, Inc. | -1.60 | |
BBIO | D | BridgeBio Pharma, Inc. | 1.29 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Medicine
Drugs
Life Sciences
Solid Tumors
Autoimmune Disease
Blastoma
Clinical Medicine
Immunotherapies
Lymphoma
Monoclonal Antibodies
Peptides
Prostate Cancer
Acute Intermittent Porphyria
Acute Myeloid Leukemia
Adenosine
Alcohol
Alnylam Pharmaceuticals
Alpha 1 Antitrypsin Deficiency
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GERM | B | ETFMG Treatments Testing and Advancements ETF | 6.15 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 4.87 | |
BBP | C | BioShares Biotechnology Products Fund | 4.72 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 4.47 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 3.85 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Cancer
Medicine
Drugs
Life Sciences
Solid Tumors
Autoimmune Disease
Blastoma
Clinical Medicine
Immunotherapies
Lymphoma
Monoclonal Antibodies
Peptides
Prostate Cancer
Acute Intermittent Porphyria
Acute Myeloid Leukemia
Adenosine
Alcohol
Alnylam Pharmaceuticals
Alpha 1 Antitrypsin Deficiency
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- VastHornet167 on STEM
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
From the Blog
Featured Articles